Valneva (VALN)
(Real Time Quote from BATS)
$7.45 USD
+0.23 (3.21%)
Updated Aug 4, 2025 11:48 AM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VALN 7.45 +0.23(3.21%)
Will VALN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VALN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VALN
Valneva (VALN) Soars 17.4%: Is Further Upside Left in the Stock?
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study
VALN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cooper Companies Q1 Earnings Likely to Reflect Seasonal Trends
Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock
Other News for VALN
Valneva (VALN) Partners with AGC Biologics for Shigella Vaccine Development
Valneva signs development, manufacturing agreement with AGC Biologics
AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's ...
MP Materials, CoreWeave, Trade Desk And Other Big Stocks Moving Higher On Tuesday
EMA Lifts Suspension on Valneva's (VALN) Chikungunya Vaccine for Seniors